ScoreWhy is Improve Medical Instruments Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.84%
- The company has been able to generate a Return on Capital Employed (avg) of 1.84% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -8.20% and Operating profit at -185.09% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 3.41% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -8.20% and Operating profit at -185.09% over the last 5 years
4
With a growth in Net Profit of 17.69%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CNY 135.4 MM
- ROCE(HY) Highest at -7.83%
- DEBT-EQUITY RATIO (HY) Lowest at 6.27 %
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 29.77%, its profits have risen by 39.4%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Improve Medical Instruments Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Improve Medical Instruments Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Improve Medical Instruments Co., Ltd.
29.77%
1.95
46.70%
China Shanghai Composite
15.45%
1.03
14.98%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-8.20%
EBIT Growth (5y)
-185.09%
EBIT to Interest (avg)
-1.98
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.59
Tax Ratio
0.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.84%
ROE (avg)
3.41%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.78
EV to EBIT
-40.69
EV to EBITDA
-83.68
EV to Capital Employed
3.78
EV to Sales
4.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.28%
ROE (Latest)
-7.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 135.4 MM
ROCE(HY)
Highest at -7.83%
DEBT-EQUITY RATIO
(HY)
Lowest at 6.27 %
RAW MATERIAL COST(Y)
Fallen by -25.66% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 3.58 times
PRE-TAX PROFIT(Q)
Highest at CNY 9.64 MM
NET PROFIT(Q)
Highest at CNY 10.92 MM
EPS(Q)
Highest at CNY 0.03
-9What is not working for the Company
CASH AND EQV(HY)
Lowest at CNY 305.63 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.65 times
NET SALES(Q)
At CNY 118.27 MM has Fallen at -8.87%
Here's what is working for Improve Medical Instruments Co., Ltd.
Operating Cash Flow
Highest at CNY 135.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY 9.64 MM has Grown at 165.42%
over average net sales of the previous four periods of CNY -14.74 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 10.92 MM has Grown at 202.91%
over average net sales of the previous four periods of CNY -10.61 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at 6.27 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
Highest at CNY 9.64 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 10.92 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.03
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Highest at 3.58 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -25.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Improve Medical Instruments Co., Ltd.
Net Sales
At CNY 118.27 MM has Fallen at -8.87%
over average net sales of the previous four periods of CNY 129.78 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Cash and Eqv
Lowest at CNY 305.63 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 2.65 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
